These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 3169684)
21. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas. Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334 [TBL] [Abstract][Full Text] [Related]
22. CD30 expression in non-Hodgkin's lymphoma. Piris M; Brown DC; Gatter KC; Mason DY Histopathology; 1990 Sep; 17(3):211-8. PubMed ID: 2173674 [TBL] [Abstract][Full Text] [Related]
23. Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines. Carbone A; Gloghini A; Gattei V; Aldinucci D; Degan M; De Paoli P; Zagonel V; Pinto A Blood; 1995 Feb; 85(3):780-9. PubMed ID: 7530508 [TBL] [Abstract][Full Text] [Related]
24. Nodular lymphocyte predominant Hodgkin's disease and anaplastic large-cell (CD30+) lymphoma: distinct entities or nonspecific patterns? Menestrina F; Chilosi M; Scarpa A Semin Diagn Pathol; 1995 Aug; 12(3):256-69. PubMed ID: 8545592 [TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibodies reactive in routinely processed tissue sections of malignant lymphoma, with emphasis on T-cell lymphomas. Strickler JG; Weiss LM; Copenhaver CM; Bindl J; McDaid R; Buck D; Warnke R Hum Pathol; 1987 Aug; 18(8):808-14. PubMed ID: 3301626 [TBL] [Abstract][Full Text] [Related]
26. Expression of B-cell antigens by Hodgkin's and Reed-Sternberg cells. Schmid C; Pan L; Diss T; Isaacson PG Am J Pathol; 1991 Oct; 139(4):701-7. PubMed ID: 1656757 [TBL] [Abstract][Full Text] [Related]
27. Inconsistency of the immunophenotype of Reed-Sternberg cells in simultaneous and consecutive specimens from the same patients. A paraffin section evaluation in 56 patients. Chu WS; Abbondanzo SL; Frizzera G Am J Pathol; 1992 Jul; 141(1):11-7. PubMed ID: 1352942 [TBL] [Abstract][Full Text] [Related]
28. Utility of combining antigranulocyte with antileukocyte antibodies in differentiating Hodgkin's disease from non-Hodgkin's lymphoma. Medeiros LJ; Weiss LM; Warnke RA; Dorfman RF Cancer; 1988 Dec; 62(12):2475-81. PubMed ID: 2973368 [TBL] [Abstract][Full Text] [Related]
29. Granulocyte and HLA-D region specific monoclonal antibodies in the diagnosis of Hodgkin's disease. Norton AJ; Isaacson PG J Clin Pathol; 1985 Nov; 38(11):1241-6. PubMed ID: 3864794 [TBL] [Abstract][Full Text] [Related]
30. The expression of the B-cell marker mb-1 (CD79a) in Hodgkin's disease. Korkolopoulou P; Cordell J; Jones M; Kaklamanis L; Tsenga A; Gatter KC; Mason DY Histopathology; 1994 Jun; 24(6):511-5. PubMed ID: 7520411 [TBL] [Abstract][Full Text] [Related]
31. Anaplastic large cell lymphoma, CD30/Ki-1 positive, expressing the CD15/Leu-M1 antigen. Immunohistochemical and morphological relationships to Hodgkin's disease. Rosso R; Paulli M; Magrini U; Kindl S; Boveri E; Volpato G; Poggi S; Baglioni P; Pileri S Virchows Arch A Pathol Anat Histopathol; 1990; 416(3):229-35. PubMed ID: 1967860 [TBL] [Abstract][Full Text] [Related]
32. CD30 expression utilization for the accuracy of classical Hodgkin's lymphoma staging. Flangea C; Potencz E; Mihăescu R; Anghel A; Gîju S; Motoc M; Dogaru C Rom J Morphol Embryol; 2006; 47(2):113-7. PubMed ID: 17106517 [TBL] [Abstract][Full Text] [Related]
33. Leucocyte-specific protein (LSP1) in malignant lymphoma and Hodgkin's disease. Marafioti T; Jabri L; Pulford K; Brousset P; Mason DY; Delsol G Br J Haematol; 2003 Feb; 120(4):671-8. PubMed ID: 12588355 [TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibody L26: an antibody that is reactive with normal and neoplastic B lymphocytes in routinely fixed and paraffin wax embedded tissues. Norton AJ; Isaacson PG J Clin Pathol; 1987 Dec; 40(12):1405-12. PubMed ID: 3323247 [TBL] [Abstract][Full Text] [Related]
35. Usefulness of K-1 (CD-30) marker in Hodgkin's disease. Shakoor KA; Saleh A; Khanzada MS J Pak Med Assoc; 2002 Oct; 52(10):442-7. PubMed ID: 12553671 [TBL] [Abstract][Full Text] [Related]
36. Clusterin expression in malignant lymphomas: a survey of 266 cases. Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802 [TBL] [Abstract][Full Text] [Related]
37. Immunopathology of Hodgkin's disease. Characterization of Reed-Sternberg cells with monoclonal antibodies. Strauchen JA; Dimitriu-Bona A Am J Pathol; 1986 May; 123(2):293-300. PubMed ID: 3085509 [TBL] [Abstract][Full Text] [Related]
38. [The immunological characterization of 63 cases of Hodgkin's disease with a panel of 8 antibodies]. Oliva-Aldamiz H; Echezarreta G; Aguilera B; Cuevas E; Barat A; Sarasa JL; Renedo G; Rivas F; Forteza J; Sánchez-Fayos MP Rev Clin Esp; 1992 Mar; 190(5):229-37. PubMed ID: 1374567 [TBL] [Abstract][Full Text] [Related]
39. Leu-22: a preferential marker for T-lymphocytes in paraffin sections. Staining profile in T- and B-cell lymphomas, Hodgkin's disease, other lymphoproliferative disorders, myeloproliferative diseases, and various neoplastic processes. Said JW; Stoll PN; Shintaku P; Bindl JM; Butmarc JR; Pinkus GS Am J Clin Pathol; 1989 May; 91(5):542-9. PubMed ID: 2785753 [TBL] [Abstract][Full Text] [Related]
40. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation? Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]